Transactions Portfolio

We are dedicate to building future life science champions. Browse our portfolio of successful transactions to see how we are the partner of choice in advising the advance of healthcare innovation.

Harrison Hayes'

Global presence

As our global track record illustrates, we partner with our clients to deliver deep sector learnings and comprehensive connectivity to provide trusted advice.
$0
Billion in financing
0
Transactions across 148 territories
Sorry, we did not find what you are looking for.
{{ item.tileTitle }}
Harrison Hayes Represented

Novasite in its Identification and Acquisition of PsyCheNomicS, a drug discovery company focused on diseases of the central nervous system (CNS)

Harrison Hayes Represented

Addrenex Pharmaceuticals to Identify and negotiate an In-Licensing Transaction with SK Life Sciences for ADX-N05 (Indicated for Narcolepsy)

Harrison Hayes Represented

Aurobindo in their Acquisition of Pharmacin

Harrison Hayes Represented

Mallinckrodt in their Strategic Alliance with Zydus Cadila

Harrison Hayes Represented

Noven Pharmaceuticals is its Acquisition of JDS Pharmaceuticals (Lithobid for bipolar disorder and Pexeva for depression)

Harrison Hayes Represented

XTL Biopharmaceuticals in the Identification and Negotiation of an In-Licensing Transaction with DOV Pharmaceutical for the worldwide rights for Bicifadine, a serontonin and norepinephrine reuptake inhibitor (SNRI)

Harrison Hayes Represented

Organon in its Acquisition of Kadmus Pharmaceuticals’ FAAH Inhibitor Technology

Harrison Hayes Represented

Imaxio in the Identification and Negotiation of its Vaccine Licensing Agreement with Isis, the Technology Transfer Arm of Oxford University.

Harrison Hayes Represented

Anteo Diagnostics in its Licensing Agreement with Malaysian based DioSion Diagnostics.

Harrison Hayes was Engaged

by Dalian Medical University (China) to conduct a Portfolio Analysis and Strategy Assessment of its Life Science Intellectual Property Assets

Harrison Hayes Represented

Serono/InterLab in the Identification and In-Licensing Transaction of Rebif (Frone) from The Weizmann Institute of Science

Harrison Hayes Represented

Adiana in its Divestiture to Cytyc

Contact us

Refer yourself here or call us on 704 906 3402

What sets us apart About us Our expertise Services & Sectors Our portfiolio Transactions We're here to help Contact us